Health and Social Problems Associated with Recent Novel Psychoactive Substance (NPS) Use Amongst Marginalised, Nightlife and Online Users in Six European Countries
Authors:
- Marie Claire Van HoutMHMarie Claire Van Hout
- Annemieke BenschopABAnnemieke Benschop
- Michal BujalskiMBMichal Bujalski
- Katarzyna DąbrowskaKDKatarzyna Dąbrowska
- Zsolt DemetrovicsZDZsolt Demetrovics
- Katalin FelvincziKFKatalin Felvinczi
- Evelyn HearneEHEvelyn Hearne
- Susana HenriquesSHSusana Henriques
- Zsuzsa KalóZKZsuzsa Kaló
- Gerrit KamphausenGKGerrit Kamphausen
- Dirk KorfDKDirk Korf
- Joana Paula SilvaJSJoana Paula Silva
Open Access
- 7 December 2017
- journal article
- research article
- Published by Springer Nature in International Journal of Mental Health and Addiction
- Vol. 16 (2) , 480-495
Abstract
Continued diversification and use of new psychoactive substances (NPS) across Europe remains a public health challenge. The study describes health and social consequences of recent NPS use as reported in a survey of marginalised, nightlife and online NPS users in the Netherlands, Hungary, Portugal, Ireland, Germany and Poland (n = 3023). Some respondents were unable to categorise NPS they had used. Use of ‘herbal blends’ and ‘synthetic cannabinoids obtained pure’ was most reported in Germany, Poland and Hungary, and use of ‘branded stimulants’ and ‘stimulants/empathogens/nootropics obtained pure’ was most reported in the Netherlands. Increased heart rate and palpitation, dizziness, anxiety, horror trips and headaches were most commonly reported acute side effects. Marginalised users reported substantially more acute side effects, more mid- and long-term mental and physical problems, and more social problems. Development of country-specific NPS awareness raising initiatives, health and social service needs assessments, and targeted responses are warranted.Keywords
Funding Information
- DG Justice (The NPS Transnational project received funding under NPS- HOME/2014/JDRU/AG/DRUG/7077.)
This publication has 58 references indexed in Scilit:
- ‘Our favourite drug’: prevalence of use and preference for mephedrone in the London night-time economy 1 year after controlJournal of Substance Use, 2012
- Spontaneous subcutaneous emphysema associated with mephedrone usageThe Annals of The Royal College of Surgeons of England, 2012
- “A Costly Turn On”: Patterns of use and perceived consequences of mephedrone based head shop products amongst Irish injectorsInternational Journal of Drug Policy, 2012
- 4-Methylmethcathinone (Mephedrone): Neuropharmacological Effects of a Designer Stimulant of AbuseThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Experiences with mephedrone pre- and post-legislative controls: Perceptions of safety and sources of supplyInternational Journal of Drug Policy, 2011
- The rise in legal highs: prevalence and patterns in the use of illegal drugs and first- and second-generation “legal highs” in South London gay dance clubsJournal of Substance Use, 2010
- WARNING: LEGAL SYNTHETIC CANNABINOID‐RECEPTOR AGONISTS SUCH AS JWH‐018 MAY PRECIPITATE PSYCHOSIS IN VULNERABLE INDIVIDUALSAddiction, 2010
- Amphetamine-group substances and HIVThe Lancet, 2010
- Mephedrone use and associated adverse effects in school and college/university students before the UK legislation changeQJM: An International Journal of Medicine, 2010
- Legal Highs on the InternetSubstance Use & Misuse, 2010